Mobile app recognises COVID-19 infection
Dutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings.
Pleco Therapeutics raises 17.3m in Series A
Dutch Pleco Therapeutics BV has raised 17.3m in a Series A financing to push its lead candidate in acute myeloid leukaemia to market approval.
Emergence Therapeutics licences Synaffix platform
Synaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence.
Abivax SA bags 49.2m to push ABX-464
Paris-based Abivax SA has cashed in 49.2m in an oversubscribed financing with top-tier US and European biotech investors.
BioEcho Life Sciences launches US subsidiary
German nucleic acid extraction specialist BioEcho Life Sciences has opened a subsidiary in Boston to supply the huge US-american market.
Belgian researchers create extraembryonic mesoderm cells
Researchers from KU Leuven for the first time have produced human cells able to mimic the molecular mechanisms of early human embryogenesis and related defects.
SARS-CoV-2 infection triggers chronic fatigue syndrome
A small prospective study among mid-aged people has demonstrated that a mild SARS-CoV-2 infection triggers ME/CF in 50% of the study population.<button lang="en-GB" aria-description="Klicken, um Alternative zu verwenden">
</button>
Danish Bactolife A/S grabs funding
Swedish food and feed supplement specialist Bactolife A/S has received US$5m in funding from the Bill & Melinda Gates Foundation to address gastrointestinal infections.
Moderna launches patent dispute with BioNTech/Pfizer
For the second time within a short period of time, a competitor has sued the mRNA vaccine developer BioNtechPfizer for patent infringement.
Belgian eTheRNA raises 39m in Series B2 financing
Moderna co-founder Kenneth Chien and Novalis LifeSciences LLC are the lead investors of a 39m Series B2 financing in eTheRNA.